Location History:
- Cantania, IT (2008)
- Catania CT, IT (2010)
- Catania, IT (2010 - 2015)
Company Filing History:
Years Active: 2008-2015
Title: Giuseppe Salvia: Innovator in Recombinant Protein Technology
Introduction
Giuseppe Salvia is a notable inventor based in Catania, Italy. He has made significant contributions to the field of recombinant protein technology, particularly in the development of placental growth factor derivatives. With a total of 4 patents to his name, Salvia's work has implications in both therapeutic and cosmetic applications.
Latest Patents
One of his latest patents is titled "PlGF-1 in homodimeric form." This invention relates to a new homodimeric form of recombinant PlGF-1, detailing a process for its preparation and the compositions that contain it. Another significant patent is "Muteins of placental growth factor type I, preparation method and application thereof." This invention focuses on chemically stable muteins of type 1 Placental Growth Factor (PLGF-1) that involve the substitution or elimination of a cysteine residue from the wild type protein amino acid sequence. The patent outlines their preparation, therapeutic and cosmetic uses, and the production of antibodies for these derivatives, which can be utilized in the diagnosis and treatment of various pathologies.
Career Highlights
Throughout his career, Giuseppe Salvia has worked with prominent companies such as Geymonat S.p.a. and Dompe S.p.a. His experience in these organizations has allowed him to refine his expertise in the field of biotechnology and contribute to innovative solutions in health and medicine.
Collaborations
Salvia has collaborated with notable professionals in his field, including Domenico Maglione and Mauro Battisti. These partnerships have further enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Giuseppe Salvia's contributions to recombinant protein technology exemplify the innovative spirit of modern science. His patents not only advance the understanding of placental growth factors but also pave the way for new therapeutic and cosmetic applications.